Use of Tyrosine Kinase Inhibitors in Patients With GI Stromal Tumor Who Are Pregnant or Considering Pregnancy: Driver Mutations and Circulating Tumor DNA

J Clin Oncol. 2018 Sep 1;36(25):2659-2660. doi: 10.1200/JCO.2018.79.0501. Epub 2018 May 31.

Authors

Vaia Florou¹, Jeremy L Ramdial¹, Jonathan C Trent¹

Affiliation

¹ Vaia Florou, Jeremy L. Ramdial, and Jonathan C. Trent, University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center, Miami, FL.

PMID: 29851548
DOI: 10.1200/JCO.2018.79.0501

No abstract available

Publication types

Letter
Comment

MeSH terms

Circulating Tumor DNA*
DNA, Neoplasm
Female
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
Mutation
Pregnancy
Protein-Tyrosine Kinases

Substances

Circulating Tumor DNA
DNA, Neoplasm
Protein-Tyrosine Kinases